SCHEMBL29685778

SCHEMBL29685778

Cc1ccc(OCC(F)(F)F)nn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.49
L3MBTL1 Q9Y468 3/20 0.44
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
IL1B P01584 1/20 0.42
CYP1A2 P05177 1/20 0.38
POLB P06746 1/20 0.35
MAPK1 P28482 1/20 0.35
MAPT P10636 4/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ALDH1A1 P00352 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
USP2 O75604 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
THRB P10828 1/20 0.33
G6PD P11413 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16705085 1.00 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL1HDAC1HDAC6HDAC5
SCHEMBL24637809 0.84 IL1B (0.39) SMN1; SMN2L3MBTL1HDAC1HDAC6HDAC5
SCHEMBL17562270 0.78 HDAC1 (0.36) SMN1; SMN2HDAC1HDAC6HDAC5IL1B
SCHEMBL29637301 0.77 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL1IL1BCYP1A2POLB
SCHEMBL28670107 0.77 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL1IL1BCYP1A2POLB
SCHEMBL23148685 0.77 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL1IL1BCYP1A2POLB
SCHEMBL5644659 0.77 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL1IL1BCYP1A2POLB
SCHEMBL19664476 0.76 SMN1; SMN2 (0.48) SMN1; SMN2L3MBTL1IL1BCYP1A2POLB
SCHEMBL13576998 0.75 HTT (0.46) SMN1; SMN2HDAC1HDAC6HDAC5POLB
SCHEMBL29761634 0.75 HTT (0.46) SMN1; SMN2HDAC1HDAC6HDAC5POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251624-A1 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS Amgen, Inc (US) 2023-10-04 EP disclosed
WO-2022115377-A1 TRICYCLIC CARBOXAMIDE DERIVATIVES AS PRMT5 INHIBITORS AMGEN INC. (US) 2022-06-02 WO disclosed